CHAPEL HILL, N.C., April 4, 2014 /PRNewswire/ -- In the face of technology advances and regulatory pressures, the pharmaceutical and medical device industries are changing how they approach medical education. It's in this environment of transition that many organizations are struggling to have the right staffing, investment, and delivery platforms to provide valuable education opportunities for healthcare practitioners.
Research and consulting firm Best Practices®, LLC has published a research study, "Professional Medical Education Excellence: Structures, Resources, Services & Performance Levels to Optimize Pharmaceutical Education Groups," to inform medical education leaders on current approaches to group size, service-levels, resources, and program deployment. The study - which provides segments for both pharmaceutical and medical device companies - presents medical education leaders' perspective on current and future trends for staffing, investment, and technology.
Technology-based programs will increase in the next two years in both pharma and device sectors, according to the study. However, 61 percent of pharma participants project increases of 10 percent or more, while device participants foresee an explosion with 58 percent anticipating more than 30 percent in growth. Another difference between both segments in terms of technology is the adoption of iPads/tablets into the education environment. Pharma's investing in iPads/tablets will represent, on average, 16 percent of their technology budget over the next two years. In contrast, iPads/tablets will represent 29 percent of device technology budgets in the device sector, according to respondents. One key reason for this difference is that the iPad/tablet technology is a good fit for the animations and simulations that complement device training.
The study also informs education leaders on the presence of education in emerging markets and how education groups are allocating their budget.
This study covers a number of topics, including the following:
- Organizational Fit & Geographic Focus
- Staffing Benchmarks & Program Trends
- Roles for Key Activities & Program Deployment
- Budget Benchmarks & Allocation Trends
- Trends & Directions
The research project included observations and insights from 40 leaders with 35 medical device and pharmaceutical companies. Participants included 14 medical education leaders from 10 medical device firms and 26 leaders from 25 biopharma companies.
To learn more about this report, download a complimentary report excerpt at http://www3.best-in-class.com/rr1281.htm. For related research, visit our Best Practices, LLC Web site at www.best-in-class.com/.
ABOUT BEST PRACTICES, LLC
Best Practices, LLC is a leading benchmarking, consulting and advisory services firm serving biopharmaceutical and medical device companies worldwide. Best Practices, LLC's clients include all the top 10 and 48 of the top 50 global healthcare companies. The firm conducts primary research and consulting using its comprehensive proprietary benchmarking tools and analysis. Best Practices, LLC believes in the profound principle that organizations can chart a course to superior economic performance by studying the best business practices, operating tactics and winning strategies of world-class companies.
SOURCE Best Practices, LLC